PETMED EXPRESS INC - Common Stock, $.001 Par Value (PETS) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock, $.001 Par Value
Symbol
PETS on Nasdaq
Shares outstanding
21,007,296
Price per share
$3.22
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
6,977,259
Total reported value
$17,594,055
% of total 13F portfolios
0%
Share change
-389,734
Value change
-$1,201,821
Number of holders
58
Price from insider filings
$3.22
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of PETMED EXPRESS INC - Common Stock, $.001 Par Value (PETS) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Silvercape Investments Ltd 12% +11% $7,481,118 +$810,196 2,579,696 +12% SilverCape Investments Limited 09 Dec 2025
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 4.7% $3,389,878 974,103 Hotchkis and Wiley Capital Management, LLC 31 Dec 2024
VANGUARD GROUP INC 4.7% $3,354,901 964,052 The Vanguard Group 31 Dec 2024

As of 30 Sep 2025, 58 institutional investors reported holding 6,977,259 shares of PETMED EXPRESS INC - Common Stock, $.001 Par Value (PETS). This represents 33% of the company’s total 21,007,296 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of PETMED EXPRESS INC - Common Stock, $.001 Par Value (PETS) together control 32% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
RENAISSANCE TECHNOLOGIES LLC 6% 1,268,969 -0.38% 0% $3,185,112
VANGUARD GROUP INC 4.6% 964,052 0% 0% $2,419,770
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 3.8% 788,103 -4.7% 0.01% $1,978,139
BlackRock, Inc. 2.6% 542,735 -0.38% 0% $1,362,265
FEDERATED HERMES, INC. 2.3% 482,386 +0.2% 0% $1,210,788
DIMENSIONAL FUND ADVISORS LP 2.3% 481,517 +5.4% 0% $1,208,603
OAKTOP CAPITAL MANAGEMENT II, L.P. 2.1% 435,844 0% 0.1% $1,093,968
GEODE CAPITAL MANAGEMENT, LLC 0.97% 203,463 -7.1% 0% $510,843
CITADEL ADVISORS LLC 0.87% 181,879 +40% 0% $456,516
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 0.83% 175,233 -29% 0% $439,835
Man Group plc 0.72% 151,039 +7.1% 0% $379,108
PRICE T ROWE ASSOCIATES INC /MD/ 0.57% 120,055 0% 0% $302,000
Truffle Hound Capital, LLC 0.57% 120,035 0% 0.19% $301,288
BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.51% 107,816 +164% 0.01% $270,618
AMERIPRISE FINANCIAL INC 0.5% 104,173 -27% 0% $261,474
Formidable Asset Management, LLC 0.47% 99,001 -14% 0.05% $328,683
STATE STREET CORP 0.46% 97,573 -1.7% 0% $244,908
UBS Group AG 0.41% 86,090 +11% 0% $216,086
NORTHERN TRUST CORP 0.29% 61,277 -11% 0% $153,805
Empowered Funds, LLC 0.29% 60,116 +201% 0% $150,891
AMERICAN CENTURY COMPANIES INC 0.29% 59,906 0% 0% $150,364
ROYAL BANK OF CANADA 0.19% 39,327 -54% 0% $99,000
Invesco Ltd. 0.17% 36,078 -51% 0% $90,556
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.17% 34,716 +112% 0% $87,138
CIBC Private Wealth Group LLC 0.14% 30,000 0% $75,300

Institutional Holders of PETMED EXPRESS INC - Common Stock, $.001 Par Value (PETS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 905 $2,896 -$5,622 $3.22 2
2025 Q3 6,977,259 $17,594,055 -$1,201,821 $2.51 58
2025 Q2 7,375,436 $24,585,642 -$1,852,844 $3.32 64
2025 Q1 7,865,569 $32,955,520 -$4,830,840 $4.19 72
2024 Q4 8,975,229 $43,264,129 -$2,056,912 $4.82 86
2024 Q3 9,499,069 $34,955,912 -$9,644,338 $3.68 92
2024 Q2 12,062,004 $48,853,657 -$10,510,852 $4.05 116
2024 Q1 14,628,259 $70,068,794 -$7,859,398 $4.79 112
2023 Q4 15,509,467 $117,253,738 +$12,602,057 $7.56 129
2023 Q3 13,258,944 $135,901,539 -$32,574,245 $10.25 137
2023 Q2 15,760,896 $217,549,589 -$24,550,420 $13.79 148
2023 Q1 17,308,637 $281,093,086 +$9,030,233 $16.24 163
2022 Q4 16,715,209 $295,885,547 +$3,841,866 $17.70 158
2022 Q3 16,383,469 $319,884,926 -$27,418,578 $19.52 159
2022 Q2 17,760,121 $353,462,234 +$13,809,440 $19.90 158
2022 Q1 17,076,732 $440,712,342 +$3,458,908 $25.80 166
2021 Q4 16,949,737 $428,255,284 +$6,430,707 $25.26 171
2021 Q3 16,656,564 $447,492,163 -$30,441,331 $26.87 177
2021 Q2 17,710,744 $563,648,886 +$37,310,655 $31.85 187
2021 Q1 16,386,791 $575,952,684 -$52,856,316 $35.17 198
2020 Q4 18,057,333 $578,750,488 -$16,151,108 $32.06 204
2020 Q3 18,602,966 $587,963,793 -$9,681,690 $31.62 198
2020 Q2 18,767,976 $668,677,282 +$61,033,275 $35.64 218
2020 Q1 16,894,329 $486,188,282 -$16,414,744 $28.78 196
2019 Q4 17,865,038 $420,743,094 -$4,689,801 $23.52 185
2019 Q3 17,955,094 $323,537,814 -$36,081,128 $18.02 161
2019 Q2 20,791,981 $325,743,040 -$1,751,787 $15.67 178
2019 Q1 20,034,645 $456,405,810 -$33,972,765 $22.78 195
2018 Q4 21,473,605 $499,431,923 +$28,998,363 $23.26 193
2018 Q3 19,624,210 $647,747,978 -$5,130,899 $33.01 192
2018 Q2 19,208,344 $845,955,034 -$23,381,743 $44.05 202
2018 Q1 19,788,521 $826,137,413 +$37,342,070 $41.75 201
2017 Q4 18,881,373 $859,176,999 -$67,881,141 $45.50 192
2017 Q3 20,603,806 $683,131,203 +$137,030,567 $33.15 176
2017 Q2 16,237,233 $659,339,729 +$49,746,324 $40.60 173
2017 Q1 15,343,685 $309,233,201 +$51,518,592 $20.14 148
2016 Q4 14,993,626 $345,963,268 +$4,302,139 $23.07 147
2016 Q3 15,111,591 $306,447,383 -$6,622,514 $20.28 148
2016 Q2 15,613,444 $293,016,607 -$18,957,604 $18.76 156
2016 Q1 16,454,956 $294,676,235 -$7,537,257 $17.91 152
2015 Q4 16,911,576 $289,924,561 -$12,599,706 $17.14 151
2015 Q3 17,569,776 $282,883,139 +$21,279,055 $16.10 148
2015 Q2 16,224,138 $279,988,518 +$23,771,233 $17.27 141
2015 Q1 14,494,500 $239,088,635 +$11,199,229 $16.52 140
2014 Q4 13,838,013 $199,017,063 +$7,479,602 $14.37 116
2014 Q3 13,290,404 $180,737,136 -$984,959 $13.60 120
2014 Q2 13,364,964 $180,150,971 -$7,125,290 $13.48 124
2014 Q1 13,882,037 $186,305,464 -$16,467,324 $13.41 127